Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $7.49 -0.23 (-2.92%) As of 05/21/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance The Aerovate Therapeutics (AVTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 98.81%, with a year-to-date return of -91.92%. In the past month, the stock has decreased 92.25%, reflecting recent market activity. As of the latest close, Aerovate Therapeutics traded at $7.72 with a market cap of $223.62 million and volume of 285,101 shares. Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.22%1 Month Performance-92.25%3 Month Performance-90.97%Year-To-Date Performance-91.92%1 Year Performance-98.81% AVTE Stock Chart for Thursday, May, 22, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$7.72$7.49-2.92%$7.83$7.30121,441 shs$217.10 million05/21/2025$7.42$7.72+3.98%$8.14$7.41285,101 shs$223.62 million05/20/2025$7.35$7.42+1.02%$7.64$7.05301,506 shs$215.07 million05/19/2025$7.35$7.35$7.59$7.11302,580 shs$212.90 million05/16/2025$7.55$7.40-1.99%$7.50$7.05271,381 shs$214.49 million05/15/2025$8.61$7.55-12.31%$8.66$7.4281,756 shs$218.84 million05/14/2025$8.58$8.61+0.35%$8.95$7.6981,973 shs$249.56 million05/13/2025$8.65$8.58-0.81%$9.31$8.20120,761 shs$248.69 million05/12/2025$8.65$8.65$9.40$8.4763,694 shs$250.72 million05/09/2025$9.26$9.00-2.81%$9.76$8.82310,795 shs$260.87 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$10.09$9.26-8.23%$10.41$9.25212,443 shs$268.40 million05/07/2025$11.50$10.09-12.26%$11.58$9.74424,316 shs$292.46 million05/06/2025$12.48$11.50-7.85%$13.00$11.42564,403 shs$333.33 million05/05/2025$12.48$12.48$13.47$9.66235,465 shs$361.73 million05/02/2025$9.50$10.00+5.26%$10.55$9.02220,731 shs$289.85 million05/01/2025$10.14$9.50-6.31%$10.61$9.06283,197 shs$275.36 million04/30/2025$2.68$10.14+279.07%$13.50$9.41185,426 shs$293.91 million04/29/2025$93.80$2.68-97.15%$2.77$2.631.03 million shs$77.54 million04/28/2025$93.80$93.80$96.95$92.0529,357 shs$77.68 million04/25/2025$95.20$93.80-1.47%$94.15$89.9531,520 shs$77.68 million04/24/2025$95.90$95.20-0.73%$97.30$91.70137,492 shs$78.84 million04/23/2025$96.60$95.90-0.72%$99.05$95.2014,399 shs$79.42 million04/22/2025$96.95$96.60-0.36%$100.10$95.5528,395 shs$80.00 million04/21/2025$96.25$96.95+0.73%$99.40$94.8525,510 shs$80.29 million Related Companies CureVac Stock Chart Bicara Therapeutics Stock Chart Enliven Therapeutics Stock Chart Zymeworks Stock Chart uniQure Stock Chart Chimerix Stock Chart LENZ Therapeutics Stock Chart Syndax Pharmaceuticals Stock Chart Avid Bioservices Stock Chart Cronos Group Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVTE Stock Free AVTE Stock Alerts